Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How antibiotics cause antibiotic resistance.

Heinemann1

  • 1Department of Plant and Microbial Sciences, Private Bag 4800, University of Canterbury, Christchurch, New Zealand.

Drug Discovery Today
|May 11, 1999
PubMed
Summary

Antimicrobial resistance is a growing threat due to how drugs drive pathogen evolution. Future antimicrobial drugs must be designed to avoid accelerating this resistance for continued effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

P(6) Manganocene and P(3) Cymantrene: Consequences of the Inclusion of Phosphorus Atoms in Mn-Coordinated Cyclopentadienyl Ligands This work was supported by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie. A.E., M.H., and M.Z. thank the DFG-Graduiertenkolleg ("Phosphorchemie als Bindeglied verschiedener chemischer Disziplinen" of the University of Kaiserslautern) and M.Z. also thanks the Studienstiftung des Deutschen Volkes for fellowships.

Angewandte Chemie (International ed. in English)·2000
Same author

Funding for knowledge-sake - Letter.

Drug discovery today·2000
Same author

Do antibiotics maintain antibiotic resistance?

Drug discovery today·2000
Same author

Spontaneous Assembly of a Schiff Base Tetramacrocycle We thank Professor D. Sellmann and Priv.-Doz. Dr. T. Clark (Universität Erlangen-Nürnberg) for generous suppport of this work. We also thank Professor R. Robson (University of Melbourne, Parkville, Victoria, Australia) for his interest in the results presented here. Financial support by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie is gratefully acknowledged.

Angewandte Chemie (International ed. in English)·2000
Same author

Characterization of Silylated Silicas by Inverse Gas Chromatography: Modelization of the Poly(dimethylsiloxane) Monomer Unit/Surface Interactions Using Poly(dimethylsiloxane) Oligomers as Probes

Journal of colloid and interface science·1996
Same author

Tracking algorithm for the stable spin polarization field in storage rings using stroboscopic averaging.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·1996

Area of Science:

  • Microbiology
  • Evolutionary Biology
  • Pharmacology

Background:

  • Antimicrobial agents are losing effectiveness globally.
  • Current drug development presumes targeting microbial vulnerabilities, inadvertently driving resistance.
  • The spread of resistance genes has occurred through unpredicted mechanisms.

Purpose of the Study:

  • To analyze the mechanisms by which antimicrobial resistance genes spread.
  • To propose a new strategy for developing future antimicrobial drugs that remain effective.

Main Methods:

  • The study reviews existing literature on antimicrobial resistance.
  • It analyzes the evolutionary impact of chemotherapeutics on pathogens.
  • It discusses the implications for future drug design.

Main Results:

  • Antimicrobial resistance spread is driven by the drugs themselves, influencing pathogen evolution.
  • The mechanisms of gene spread were not adequately predicted by prevailing strategies.
  • Chemotherapeutics actively shape the evolutionary trajectory of pathogens.

Conclusions:

  • Future antimicrobial drug development must account for and mitigate the evolutionary effects of the drugs on pathogens.
  • Designing drugs that do not promote resistance is crucial for sustained antimicrobial efficacy.
  • A paradigm shift in antimicrobial development is necessary to combat the escalating resistance crisis.

Related Experiment Videos